Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

4.61
+0.22505.14%
Volume:1.04M
Turnover:4.70M
Market Cap:443.43M
PE:-6.17
High:4.64
Open:4.33
Low:4.33
Close:4.38
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:0.55
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7467
EPS(LYR):-0.7467
ROE:-59.04%
ROA:-35.32%
PB:4.40
PE(LYR):-6.17

Loading ...

Rezolute FY26 Net Loss Widens 4.26% to $77.59 Million; FY26 G&A Expenses Climb 58.79% to $29.17 Million

Reuters
·
Sep 25

Rezolute Q4 EPS USD -0.2

Reuters
·
Sep 25

Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Sep 25

Rezolute Q4 Operating Expenses USD 21.562 Million

THOMSON REUTERS
·
Sep 25

Top News Today/Canada: Inflation Holds Steady at 3%

Dow Jones
·
Sep 15

Rezolute, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview

Reuters
·
Sep 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 10

Rezolute Says FDA Review Continues for Phase 3 sunRIZE Data on Ersodetug in Congenital Hyperinsulinism

Reuters
·
Sep 09

Rezolute, - Open-Label Extension Phase Ongoing with High Participation and Improved Glycemic Control

THOMSON REUTERS
·
Sep 09

Rezolute, - Enrollment Ongoing in Phase 3 Uplift Study for Tumor Hi; Results Expected Before End of 2026

THOMSON REUTERS
·
Sep 09

Rezolute, - FDA Still Reviewing Submission for Regulatory Path Forward for Ersodetug in Congenital Hi

THOMSON REUTERS
·
Sep 09

Rezolute Provides Update on FDA Review of Its Phase 3 Sunrize Study Results in Congenital Hyperinsulinism

THOMSON REUTERS
·
Sep 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 04

Rezolute Says Cash Position Totals $120 Million, Funds Operations into Mid-2028

Reuters
·
Aug 26

Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX)

TIPRANKS
·
Jul 30

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jul 14

Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar

Simply Wall St.
·
Jul 12

Rezolute Posts Corporate Deck on Phase 3 Ersodetug Program for Refractory Hypoglycemia in Hyperinsulinism

Reuters
·
Jun 27